Recently, new immune-based treatments have shown impressive results when multiple myeloma returns, changing how doctors treat patients early after relapse.

Darzalex Faspro, in combination with an anti-cancer triplet, is the first anti-CD38-based regimen for newly diagnosed ...

D-VRd is the only quadruplet regimen approved for patients with newly diagnosed multiple myeloma, irrespective of transplant ...

Even as Johnson & Johnson’s oncology superstar Darzalex Faspro racks up megablockbuster sales and reshapes the multiple ...

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...

Discover inspiring messages of hope from cancer survivors, emphasizing resilience, scientific advancements, and the ...

Many of these advances and breakthroughs are the result of decades of work and clinical trials.

Real world data show multiple myeloma survival varies by treatment line and autologous stem cell transplant status. Read more ...

The FDA approved daratumumab and hyaluronidase-fihj (Darzalex Faspro) in combination with bortezomib (Velcade), lenalidomide ...

The mother and daughter received identical diagnoses just over a year apart of multiple myeloma, a blood cancer that occurs ...

Patti Scialfa, Bruce Springsteen’s wife and a member of the E Street Band, recently shared that she was diagnosed in 2018 with a type of blood cancer called multiple myeloma. She revealed her illness ...